Rejunik 500mcg/75mg Tablet
By Rejunik
Rx
10 Tablet in a Strip

Composition
Methylcobalamin(500mcg) + Pregabalin(75mg)

Manufacturer - Himalaya Meditek Pvt Ltd
plot no.: 35&36, selaqui industrial area, pharmacity, dehradun-248197, uttarakhand, india

Expires on or after
September, 2025

liver
When it comes to the safety of using Rejunik 500mcg/75mg Tablet for patients with liver disease, the limited data currently available indicates that it is likely safe for use. It appears that there may not be a need for dose adjustments in these individuals. However, it is always important to consult with your doctor before starting or continuing any medication, including Rejunik 500mcg/75mg Tablet, especially if you have liver issues. Your doctor will be able to provide proper guidance tailored to your specific situation.

kidney
Caution should be observed when using Rejunik 500mcg/75mg Tablet in patients with kidney disease, as dose adjustment may be necessary. It is advised to consult your doctor before taking this medication.

alcohol
Rejunik 500mcg/75mg Tablet can lead to increased drowsiness when combined with alcohol.

driving
When taking Rejunik 500mcg/75mg Tablet, be cautious while driving as it may reduce alertness, cause dizziness, and affect vision. Avoid driving if you experience these symptoms.

pregnancy
Rejunik 500mcg/75mg Tablet may not be safe to use during pregnancy due to potential harm to the developing baby, as shown in animal studies. Your doctor will assess the benefits and risks before prescribing this medication. It is important to consult your doctor.

breastfeeding
Rejunik 500mcg/75mg Tablet is likely unsafe during breastfeeding, as it may pass into breast milk and harm the baby. It is better to consult your doctor before using Rejunik 500mcg/75mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | NEURO CNS |
Action Class | - |
₹134.5
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025